Egenskap
Muscle ache
Klinisk navn: Myalgia
Pain in muscle.
Sammendrag
- Også kalt
- Muscle pain
- Kroppssystem
- Constitutional symptom
ReferansegenomGRCh38hg38
Posisjoner på gen- og variantsidene følger dette valget i denne nettleseren.
Read the genes linked to Muscle ache, and the rest of your genome, with one test.
Fra 449 $Gratis frakt · Resultater på 6–8 uker
Få mitt Genome Test176 gener knyttet til Muscle ache
Endringer i disse genene forårsaker sjeldne tilstander der Muscle ache forekommer. De fleste med denne egenskapen har ingen av disse tilstandene, og et gen på denne listen sier ingenting om noens eget genom.
| Gen | Hvor ofte den forekommer | Tilstander |
|---|---|---|
| ATP2A2ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 | Alltid | I 1 tilstand |
| CR2complement C3d receptor 2 | Alltid | I 1 tilstand |
| FDX2ferredoxin 2 | Alltid | I 1 tilstand |
| GKglycerol kinase | Alltid | I 1 tilstand |
| HMGCR3-hydroxy-3-methylglutaryl-CoA reductase | Alltid | I 1 tilstand |
| JPH1junctophilin 1 | Alltid | I 1 tilstand |
| KYkyphoscoliosis peptidase | Alltid | I 1 tilstand |
| LPIN1lipin 1 | Alltid | I 1 tilstand |
| MEFVMEFV innate immunity regulator, pyrin | Alltid | I 5 tilstander |
| MIEF2mitochondrial elongation factor 2 | Alltid | I 1 tilstand |
| MPV17mitochondrial inner membrane protein MPV17 | Alltid | I 1 tilstand |
| POLG2DNA polymerase gamma 2, accessory subunit | Alltid | I 2 tilstander |
| RTN2reticulon 2 | Alltid | I 1 tilstand |
| SCN4Asodium voltage-gated channel alpha subunit 4 | Alltid | I 7 tilstander |
| SLC25A4solute carrier family 25 member 4 | Alltid | I 2 tilstander |
| AMPD1adenosine monophosphate deaminase 1 | Svært ofte (80–99 %) | I 1 tilstand |
| AMPD3adenosine monophosphate deaminase 3 | Svært ofte (80–99 %) | I 1 tilstand |
| ANO5anoctamin 5 | Svært ofte (80–99 %) | I 2 tilstander |
| C4Acomplement C4A (Chido/Rodgers blood group) | Svært ofte (80–99 %) | I 1 tilstand |
| CASQ1calsequestrin 1 | Svært ofte (80–99 %) | I 2 tilstander |
| CCR1C-C motif chemokine receptor 1 | Svært ofte (80–99 %) | I 1 tilstand |
| CNBPCCHC-type zinc finger nucleic acid binding protein | Svært ofte (80–99 %) | I 2 tilstander |
| CPT2carnitine palmitoyltransferase 2 | Svært ofte (80–99 %) | I 3 tilstander |
| DMDdystrophin | Svært ofte (80–99 %) | I 3 tilstander |
| DTNAdystrobrevin alpha | Svært ofte (80–99 %) | I 1 tilstand |
| ERAP1endoplasmic reticulum aminopeptidase 1 | Svært ofte (80–99 %) | I 1 tilstand |
| FASFas cell surface death receptor | Svært ofte (80–99 %) | I 1 tilstand |
| GLAgalactosidase alpha | Svært ofte (80–99 %) | I 1 tilstand |
| GYS1glycogen synthase 1 | Svært ofte (80–99 %) | I 1 tilstand |
| HLA-Bmajor histocompatibility complex, class I, B | Svært ofte (80–99 %) | I 3 tilstander |
| IFNGR1interferon gamma receptor 1 | Svært ofte (80–99 %) | I 1 tilstand |
| IL10interleukin 10 | Svært ofte (80–99 %) | I 1 tilstand |
| IL12Ainterleukin 12A | Svært ofte (80–99 %) | I 1 tilstand |
| IL12A-AS1IL12A antisense RNA 1 | Svært ofte (80–99 %) | I 1 tilstand |
| IL23Rinterleukin 23 receptor | Svært ofte (80–99 %) | I 1 tilstand |
| KLRC4killer cell lectin like receptor C4 | Svært ofte (80–99 %) | I 1 tilstand |
| LBRlamin B receptor | Svært ofte (80–99 %) | I 1 tilstand |
| MVKmevalonate kinase | Svært ofte (80–99 %) | I 2 tilstander |
| NLRP3NLR family pyrin domain containing 3 | Svært ofte (80–99 %) | I 5 tilstander |
| OBSCNobscurin, cytoskeletal calmodulin and titin-interacting RhoGEF | Svært ofte (80–99 %) | I 1 tilstand |
Vis 136 gener til
| Gen | Hvor ofte den forekommer | Tilstander |
|---|---|---|
| ORAI1ORAI calcium release-activated calcium modulator 1 | Svært ofte (80–99 %) | I 1 tilstand |
| PLAAT3phospholipase A and acyltransferase 3 | Svært ofte (80–99 %) | I 1 tilstand |
| STAT4signal transducer and activator of transcription 4 | Svært ofte (80–99 %) | I 2 tilstander |
| STIM1stromal interaction molecule 1 | Svært ofte (80–99 %) | I 2 tilstander |
| TLR4toll like receptor 4 | Svært ofte (80–99 %) | I 1 tilstand |
| TNFRSF1ATNF receptor superfamily member 1A | Svært ofte (80–99 %) | I 2 tilstander |
| UBAC2UBA domain containing 2 | Svært ofte (80–99 %) | I 1 tilstand |
| ACAD9acyl-CoA dehydrogenase family member 9 | Ofte (30–79 %) | I 1 tilstand |
| ADA2adenosine deaminase 2 | Ofte (30–79 %) | I 1 tilstand |
| ALDOAaldolase, fructose-bisphosphate A | Ofte (30–79 %) | I 1 tilstand |
| APCAPC regulator of Wnt signaling pathway | Ofte (30–79 %) | I 1 tilstand |
| ARVCFARVCF delta catenin family member | Ofte (30–79 %) | I 1 tilstand |
| CCDC78coiled-coil domain containing 78 | Ofte (30–79 %) | I 1 tilstand |
| CD4CD4 molecule | Ofte (30–79 %) | I 1 tilstand |
| CLCN1chloride voltage-gated channel 1 | Ofte (30–79 %) | I 3 tilstander |
| COMTcatechol-O-methyltransferase | Ofte (30–79 %) | I 1 tilstand |
| CRPPACDP-L-ribitol pyrophosphorylase A | Ofte (30–79 %) | I 2 tilstander |
| CTNNB1catenin beta 1 | Ofte (30–79 %) | I 1 tilstand |
| DNA2DNA replication helicase/nuclease 2 | Ofte (30–79 %) | I 2 tilstander |
| ENO3enolase 3 | Ofte (30–79 %) | I 2 tilstander |
| FKRPfukutin related protein | Ofte (30–79 %) | I 3 tilstander |
| FKTNfukutin | Ofte (30–79 %) | I 1 tilstand |
| GP1BBglycoprotein Ib platelet subunit beta | Ofte (30–79 %) | I 1 tilstand |
| HADHBhydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta | Ofte (30–79 %) | I 2 tilstander |
| HIRAhistone cell cycle regulator | Ofte (30–79 %) | I 1 tilstand |
| IL12Binterleukin 12B | Ofte (30–79 %) | I 1 tilstand |
| IRF4interferon regulatory factor 4 | Ofte (30–79 %) | I 1 tilstand |
| JMJD1Cjumonji domain containing 1C | Ofte (30–79 %) | I 1 tilstand |
| LPIN2lipin 2 | Ofte (30–79 %) | I 1 tilstand |
| MDM4MDM4 regulator of p53 | Ofte (30–79 %) | I 1 tilstand |
| MLXMAX dimerization protein MLX | Ofte (30–79 %) | I 1 tilstand |
| MOCOSmolybdenum cofactor sulfurase | Ofte (30–79 %) | I 1 tilstand |
| MRPS2mitochondrial ribosomal protein S2 | Ofte (30–79 %) | I 1 tilstand |
| MSTO1misato mitochondrial distribution and morphology regulator 1 | Ofte (30–79 %) | I 2 tilstander |
| MTTPmicrosomal triglyceride transfer protein | Ofte (30–79 %) | I 1 tilstand |
| MYH7myosin heavy chain 7 | Ofte (30–79 %) | I 2 tilstander |
| NLRC4NLR family CARD domain containing 4 | Ofte (30–79 %) | I 1 tilstand |
| NLRP12NLR family pyrin domain containing 12 | Ofte (30–79 %) | I 1 tilstand |
| NOD2nucleotide binding oligomerization domain containing 2 | Ofte (30–79 %) | I 1 tilstand |
| OTULINOTU deubiquitinase with linear linkage specificity | Ofte (30–79 %) | I 1 tilstand |
| PACSIN3protein kinase C and casein kinase substrate in neurons 3 | Ofte (30–79 %) | I 1 tilstand |
| PFKMphosphofructokinase, muscle | Ofte (30–79 %) | I 1 tilstand |
| PGAM2phosphoglycerate mutase 2 | Ofte (30–79 %) | I 1 tilstand |
| PHKA1phosphorylase kinase regulatory subunit alpha 1 | Ofte (30–79 %) | I 1 tilstand |
| PHKG1phosphorylase kinase catalytic subunit gamma 1 | Ofte (30–79 %) | I 1 tilstand |
| PNPLA2patatin like domain 2, triacylglycerol lipase | Ofte (30–79 %) | I 2 tilstander |
| POLR3ARNA polymerase III subunit A | Ofte (30–79 %) | I 1 tilstand |
| POMT1protein O-mannosyltransferase 1 | Ofte (30–79 %) | I 1 tilstand |
| PRDM5PR/SET domain 5 | Ofte (30–79 %) | I 1 tilstand |
| PTPN6protein tyrosine phosphatase non-receptor type 6 | Ofte (30–79 %) | I 1 tilstand |
| RNASEH1ribonuclease H1 | Ofte (30–79 %) | I 2 tilstander |
| RREB1ras responsive element binding protein 1 | Ofte (30–79 %) | I 1 tilstand |
| RRM2Bribonucleotide reductase regulatory TP53 inducible subunit M2B | Ofte (30–79 %) | I 2 tilstander |
| SDHAsuccinate dehydrogenase complex flavoprotein subunit A | Ofte (30–79 %) | I 1 tilstand |
| SEC24CSEC24 homolog C, COPII component | Ofte (30–79 %) | I 1 tilstand |
| SH3TC2SH3 domain and tetratricopeptide repeats 2 | Ofte (30–79 %) | I 1 tilstand |
| SVILsupervillin | Ofte (30–79 %) | I 1 tilstand |
| TBX1T-box transcription factor 1 | Ofte (30–79 %) | I 1 tilstand |
| TRAPPC11trafficking protein particle complex subunit 11 | Ofte (30–79 %) | I 3 tilstander |
| UFD1ubiquitin recognition factor in ER associated degradation 1 | Ofte (30–79 %) | I 1 tilstand |
| VCPvalosin containing protein | Ofte (30–79 %) | I 1 tilstand |
| VWA1von Willebrand factor A domain containing 1 | Ofte (30–79 %) | I 1 tilstand |
| ACP5acid phosphatase 5, tartrate resistant | Noen ganger (5–29 %) | I 1 tilstand |
| AIPAHR interacting HSP90 co-chaperone | Noen ganger (5–29 %) | I 1 tilstand |
| ALDH4A1aldehyde dehydrogenase 4 family member A1 | Noen ganger (5–29 %) | I 1 tilstand |
| ANK1ankyrin 1 | Noen ganger (5–29 %) | I 1 tilstand |
| ANKRD55ankyrin repeat domain 55 | Noen ganger (5–29 %) | I 1 tilstand |
| ASXL1ASXL transcriptional regulator 1 | Noen ganger (5–29 %) | I 1 tilstand |
| CAVIN1caveolae associated protein 1 | Noen ganger (5–29 %) | I 1 tilstand |
| CD247CD247 molecule | Noen ganger (5–29 %) | I 1 tilstand |
| CTLA4cytotoxic T-lymphocyte associated protein 4 | Noen ganger (5–29 %) | I 1 tilstand |
| DCCDCC netrin 1 receptor | Noen ganger (5–29 %) | I 1 tilstand |
| DGUOKdeoxyguanosine kinase | Noen ganger (5–29 %) | I 1 tilstand |
| DNAJB6DnaJ heat shock protein family (Hsp40) member B6 | Noen ganger (5–29 %) | I 1 tilstand |
| DNAL4dynein axonemal light chain 4 | Noen ganger (5–29 %) | I 1 tilstand |
| DNASE1L3deoxyribonuclease 1L3 | Noen ganger (5–29 %) | I 1 tilstand |
| DYSFdysferlin | Noen ganger (5–29 %) | I 1 tilstand |
| EPB42erythrocyte membrane protein band 4.2 | Noen ganger (5–29 %) | I 1 tilstand |
| EXT1exostosin glycosyltransferase 1 | Noen ganger (5–29 %) | I 1 tilstand |
| EXT2exostosin glycosyltransferase 2 | Noen ganger (5–29 %) | I 1 tilstand |
| FMR1fragile X messenger ribonucleoprotein 1 | Noen ganger (5–29 %) | I 2 tilstander |
| GPR101G protein-coupled receptor 101 | Noen ganger (5–29 %) | I 1 tilstand |
| HADHAhydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha | Noen ganger (5–29 %) | I 2 tilstander |
| HLA-DPA1major histocompatibility complex, class II, DP alpha 1 | Noen ganger (5–29 %) | I 1 tilstand |
| HLA-DPB1major histocompatibility complex, class II, DP beta 1 | Noen ganger (5–29 %) | I 1 tilstand |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Noen ganger (5–29 %) | I 1 tilstand |
| HPDL4-hydroxyphenylpyruvate dioxygenase like | Noen ganger (5–29 %) | I 1 tilstand |
| HSPG2heparan sulfate proteoglycan 2 | Noen ganger (5–29 %) | I 1 tilstand |
| IGHG2immunoglobulin heavy constant gamma 2 (G2m marker) | Noen ganger (5–29 %) | I 1 tilstand |
| IGKCimmunoglobulin kappa constant | Noen ganger (5–29 %) | I 1 tilstand |
| IL2RAinterleukin 2 receptor subunit alpha | Noen ganger (5–29 %) | I 1 tilstand |
| IL2RBinterleukin 2 receptor subunit beta | Noen ganger (5–29 %) | I 1 tilstand |
| KITKIT proto-oncogene, receptor tyrosine kinase | Noen ganger (5–29 %) | I 1 tilstand |
| LMNAlamin A/C | Noen ganger (5–29 %) | I 3 tilstander |
| LMNB1lamin B1 | Noen ganger (5–29 %) | I 1 tilstand |
| LRP12LDL receptor related protein 12 | Noen ganger (5–29 %) | I 1 tilstand |
| MT-TEmitochondrially encoded tRNA-Glu (GAA/G) | Noen ganger (5–29 %) | I 1 tilstand |
| MT-TKmitochondrially encoded tRNA-Lys (AAA/G) | Noen ganger (5–29 %) | I 1 tilstand |
| NTN1netrin 1 | Noen ganger (5–29 %) | I 1 tilstand |
| P4HA2prolyl 4-hydroxylase subunit alpha 2 | Noen ganger (5–29 %) | I 1 tilstand |
| PHKA2phosphorylase kinase regulatory subunit alpha 2 | Noen ganger (5–29 %) | I 1 tilstand |
| PHKBphosphorylase kinase regulatory subunit beta | Noen ganger (5–29 %) | I 1 tilstand |
| PHKG2phosphorylase kinase catalytic subunit gamma 2 | Noen ganger (5–29 %) | I 1 tilstand |
| PLD4phospholipase D family member 4 | Noen ganger (5–29 %) | I 1 tilstand |
| POLGDNA polymerase gamma, catalytic subunit | Noen ganger (5–29 %) | I 1 tilstand |
| PPARGperoxisome proliferator activated receptor gamma | Noen ganger (5–29 %) | I 1 tilstand |
| PRORPprotein only RNase P catalytic subunit | Noen ganger (5–29 %) | I 1 tilstand |
| PRTN3proteinase 3 | Noen ganger (5–29 %) | I 1 tilstand |
| PTPN2protein tyrosine phosphatase non-receptor type 2 | Noen ganger (5–29 %) | I 1 tilstand |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Noen ganger (5–29 %) | I 3 tilstander |
| RAD51RAD51 recombinase | Noen ganger (5–29 %) | I 1 tilstand |
| SLC4A1solute carrier family 4 member 1 (Diego blood group) | Noen ganger (5–29 %) | I 1 tilstand |
| SPTA1spectrin alpha, erythrocytic 1 | Noen ganger (5–29 %) | I 1 tilstand |
| SPTBspectrin beta, erythrocytic | Noen ganger (5–29 %) | I 1 tilstand |
| SRSF2serine and arginine rich splicing factor 2 | Noen ganger (5–29 %) | I 1 tilstand |
| TET2tet methylcytosine dioxygenase 2 | Noen ganger (5–29 %) | I 1 tilstand |
| TNXBtenascin XB | Noen ganger (5–29 %) | I 1 tilstand |
| TWNKtwinkle mtDNA helicase | Noen ganger (5–29 %) | I 2 tilstander |
| ALMS1ALMS1 centrosome and basal body associated protein | Sjelden (1–4%) | I 1 tilstand |
| CAV3caveolin 3 | Sjelden (1–4%) | I 2 tilstander |
| CLCNKBchloride voltage-gated channel Kb | Sjelden (1–4%) | I 1 tilstand |
| DNM1Ldynamin 1L | Sjelden (1–4%) | I 1 tilstand |
| FLNCfilamin C | Sjelden (1–4%) | I 1 tilstand |
| OPA1OPA1 mitochondrial dynamin like GTPase | Sjelden (1–4%) | I 1 tilstand |
| PPIBpeptidylprolyl isomerase B | Sjelden (1–4%) | I 1 tilstand |
| SLC12A3solute carrier family 12 member 3 | Sjelden (1–4%) | I 1 tilstand |
| CAPN3calpain 3 | Ikke registrert | I 1 tilstand |
| COX6B1cytochrome c oxidase subunit 6B1 | Ikke registrert | I 1 tilstand |
| DSEdermatan sulfate epimerase | Ikke registrert | I 1 tilstand |
| LDHAlactate dehydrogenase A | Ikke registrert | I 1 tilstand |
| MYOTmyotilin | Ikke registrert | I 1 tilstand |
| PDGFRAplatelet derived growth factor receptor alpha | Ikke registrert | I 1 tilstand |
| POPDC1popeye domain cAMP effector 1 | Ikke registrert | I 1 tilstand |
| RBCK1RANBP2-type and C3HC4-type zinc finger containing 1 | Ikke registrert | I 1 tilstand |
| SCN9Asodium voltage-gated channel alpha subunit 9 | Ikke registrert | I 1 tilstand |
| TMEM126Btransmembrane protein 126B | Ikke registrert | I 1 tilstand |
Hvor ofte dette forekommer hos personer med en av genets tilstander, oppgitt som den hyppigste forekomsten blant dem, slik Human Phenotype Ontology registrerer den. Disse sidene beskriver egenskaper og forskningen bak dem. De er ikke en diagnose, og om symptomer bør du spørre lege eller genetisk rådgiver.
Smalere egenskaper
Bredere egenskaper
Slik er informasjonen samlet
- Human Phenotype Ontology, versjon 2026-09-01: egenskapen, navnene på den, definisjonen og genene som er knyttet til den. Les mer på hpo.jax.org.
- Datautgave 2026.10.16-c6eea6bf.
Én test. En livstid med svar.
Fra 449 $Gratis frakt · Resultater på 6–8 uker